To further expand the understating of PCD-related effect of combination therapy on CLL cells, the expression level of two PCD regulating genes, Bax (apoptotic) and Bcl-2 (anti-apoptotic), were evaluated. The gene discussed is BAX; the disease is B-cell chronic lymphocytic leukemia.